Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cladribine: mode of action and implications for treatment of multiple sclerosis.
Robotic therapy: the tipping point.
Myelination: Do Astrocytes Play a Role?
Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta.
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes.
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.
Cigarette smoking and the risk of multiple sclerosis: a sibling case-control study in Isfahan, Iran.
Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using optical coherence tomography.
Social and economic burden of walking and mobility problems in multiple sclerosis.
Aerobic and resistance exercise improve walking speed and endurance in people with multiple sclerosis (commentary).
Nitric oxide inhibits CXCL12 expression in neuroinflammation.
Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
Influence of Peripheral inflammation on the progression of Multiple Sclerosis: Evidence from the clinic and experimental animal models.
Enhanced Action Potential Passage Through the Node of Ranvier of Myelinated Axons via Proton Hopping.
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
Leukoencephalopathy due to Oral Methotrexate.
Lack of association between AQP4 polymorphisms and risk of inflammatory demyelinating disease in a Korean population.
Cognitive Trajectories in 4 Patients With Pediatric-Onset Multiple Sclerosis: Serial Evaluation Over a Decade.
Patient Characteristics Associated with Medication Adherence.
Revisiting the management of fatigue in multiple sclerosis in the context of rehabilitation: a narrative review of current evidence.
Imaging resting state brain function in multiple sclerosis.
SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy.
Sex ratio of infectious mononucleosis and possible relevance to multiple sclerosis.

Pages